Dashboard
Manage Tickers

LNSR LENSAR, Inc.

Nasdaq lensar.com


$ 12.29 $ 0.36 (3 %)    

Friday, 31-Oct-2025 13:19:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 627.20 $ -6.80 (-1.07 %)
DIA $ 473.68 $ -2.22 (-0.47 %)
SPY $ 679.83 $ -5.11 (-0.77 %)
TLT $ 90.23 $ -0.32 (-0.36 %)
GLD $ 366.98 $ -3.49 (-0.94 %)
$ 12.05
$ 12.00
$ 12.19 x 17
$ 12.33 x 50
$ 12.15 - $ 12.36
$ 5.28 - $ 17.31
31,757
na
143.81M
$ 0.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-04-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-16-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-12-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

lensar-q2-eps-015-compared-with-079-yoy-sales-13935m-miss-16550m-estimate
LENSAR Q2 EPS $(0.15) Compared With $(0.79...
08/07/2025 11:28:46

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.02) by 6...

alcon-secures-first-fda-approval-since-novartis-spin-off-in-2019
Alcon Secures First FDA Approval Since Nov...
05/29/2025 17:28:03

FDA approves Alcon's Tryptyr for dry eye disease, backed by Phase 3 trials showing strong efficacy in increasing natural te...

lensar-q1-eps-232-misses-021-estimate-sales-1416m-beat-1340m-estimate
LENSAR Q1 EPS $(2.32) Misses $(0.21) Estim...
05/08/2025 11:27:51

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(2.32) per share which missed the analyst consensus estimate of $(0.21) by 1...

alcon-eyes-surgical-edge-with-lensar-buyout-details
Alcon Eyes Surgical Edge With LENSAR Buyou...
03/24/2025 14:24:10

Alcon is set to acquire LENSAR Inc. in a $356 million deal. This acquisition includes LENSAR's advanced cataract laser tech...

Core News & Articles
Alcon To Acquire LENSAR For $14/Share
03/24/2025 12:12:05

lake-street-maintains-buy-on-lensar-raises-price-target-to-16
Lake Street Maintains Buy on LENSAR, Raise...
02/28/2025 16:59:33

Lake Street analyst Frank Takkinen maintains LENSAR (NASDAQ:LNSR) with a Buy and raises the price target from $12 to $16.

lensar-q4-eps-161-misses-018-estimate-sales-1673m-beat-1490m-estimate
LENSAR Q4 EPS $(1.61) Misses $(0.18) Estim...
02/27/2025 12:14:45

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(1.61) per share which missed the analyst consensus estimate of $(0.18) by 7...

earnings-scheduled-for-february-27-2025
Earnings Scheduled For February 27, 2025
02/27/2025 08:32:34

lensar-q3-2024-gaap-eps-013-beats-027-estimate-sales-13539m-beat-11500m-estimate
LENSAR Q3 2024 GAAP EPS $(0.13) Beats $(0....
11/07/2024 14:02:19

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.27) by 51....

lensar-q2-2024-adj-eps-046-misses-029-estimate-sales-12636m-beat-12150m-estimate
LENSAR Q2 2024 Adj. EPS $(0.46) Misses $(0...
08/08/2024 11:30:37

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.29) by 5...

lensar-announced-that-the-ally-adaptive-cataract-treatment-system-has-received-certification-under-the-european-unions-eu-medical-device-regulation-mdr
LENSAR Announced That The ALLY Adaptive Ca...
08/07/2024 11:25:13

lensar-q1-2024-gaap-eps-019-beats-028-estimate-sales-10588m-beat-10550m-estimate
LENSAR Q1 2024 GAAP EPS $(0.19) Beats $(0....
05/09/2024 11:13:01

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.28) by 32....

lake-street-initiates-coverage-on-lensar-with-buy-rating-announces-price-target-of-8
Lake Street Initiates Coverage On LENSAR w...
03/19/2024 17:40:05

Lake Street initiates coverage on LENSAR (NASDAQ:LNSR) with a Buy rating and announces Price Target of $8.

lensar-q4-eps-035-misses-022-estimate-sales-1211m-beat-1200m-estimate
LENSAR Q4 EPS $(0.35) Misses $(0.22) Estim...
03/04/2024 12:02:39

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.22) by 5...

earnings-scheduled-for-march-4-2024
Earnings Scheduled For March 4, 2024
03/04/2024 09:53:45

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter.

earnings-preview-lensar
Earnings Preview: LENSAR
03/01/2024 15:02:11

lensar-q3-eps-023-beats-034-estimate-sales-979m-miss-1020m-estimate
LENSAR Q3 EPS $(0.23) Beats $(0.34) Estima...
11/09/2023 12:08:30

LENSAR (NASDAQ:LNSR) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.34) by 32....

earnings-scheduled-for-november-9-2023
Earnings Scheduled For November 9, 2023
11/09/2023 11:52:51

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

lensars-earnings-outlook
LENSAR's Earnings Outlook
11/08/2023 17:01:49

why-nanovibronix-shares-are-trading-higher-by-49-here-are-20-stocks-moving-premarket
Why NanoVibronix Shares Are Trading Higher...
08/30/2023 13:14:40

Gainers AgileThought, Inc. (NASDAQ: AGIL) rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION